[Update on current care guidelines. Parkinson's disease]

Duodecim. 2010;126(19):2289-90.
[Article in Finnish]

Abstract

Following the diagnosis of Parkinson's disease, treatment may be initiated with MAO-B-inhibitor, even prior to the development of any functional deficit. For patients with a functional deficit who are younger (usually under 75 years of age) and otherwise in good condition, treatment should be started with a dopamine agonist or MAO-B-inhibitor. In other patients, initial treatment with levodopa is recommended. In the case of difficult on-off-symptoms and dyskinesias in spite of optimal treatment, surgical procedures and duodenal levodopa infusion should be considered. Rehabilitation should be targeted at specific problems associated with functional skills.

Publication types

  • English Abstract

MeSH terms

  • Age Factors
  • Aged
  • Antiparkinson Agents / therapeutic use*
  • Dopamine Agonists / therapeutic use
  • Dyskinesias / drug therapy
  • Humans
  • Levodopa / therapeutic use
  • Middle Aged
  • Monoamine Oxidase Inhibitors / therapeutic use
  • Parkinson Disease / drug therapy*
  • Practice Guidelines as Topic*

Substances

  • Antiparkinson Agents
  • Dopamine Agonists
  • Monoamine Oxidase Inhibitors
  • Levodopa